Clinical Trial Update: Study on Safety and Efficacy of UCB-MNCs for Radiation-induced Lung Injury [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial is evaluating the safety and efficacy of umbilical cord blood mononuclear cells for radiation-induced lung injury. The study is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation-induced Lung Injury

Drugs mentioned

• UCB-MNCs (Umbilical cord blood mononuclear cells)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Radiation-induced Lung Injury | EARLY_Phase 1 | Status: NOT_YET_RECRUITING